Skip to main content
. 2011 May 5;39(4):341–352. doi: 10.1007/s15010-011-0121-9

Table 7.

Influence of antiviral treatment with oseltamivir on the duration of fever, risk of severe disease and survival in patients hospitalised with 2009 pandemic H1N1 infection

Oseltamivir No antiviral treatment P-value
Duration of fever (days) 2.59 (159 patients) 3.25 (57 patients) 0.01
ICU admission 28/420 (6.7%) 21/120 (17.5%) 0.001
Death 9/241 (3.7%) 5/100 (5.0%) 0.56